Quick answer
Exosomes are nanovesicles every cell releases to signal to others, carrying proteins, lipids and small genetic material. EHL Bio is developing exosomes from adipose mesenchymal stem cells, with neuropathic pain as the lead indication, currently in animal studies supporting patent filings. Additional targets under study include cartilage regeneration, wound healing, diabetes, retinopathy and brain disorders.
What exosomes are and why they appeal
Theoretically, exosomes have no nucleus and do not divide, so they avoid the abnormal-growth concerns of whole cells; their nanoscale size also improves tissue distribution and makes storage simpler.
The applications EHL is targeting
EHL lists target uses across pain control, cartilage regeneration, wound healing, hypertension, Alzheimer's, retinopathy, Parkinson's and diabetes, with complex pain syndrome as the most advanced programme.
Telling therapeutic exosomes from cosmetic claims
The word 'exosome' is used loosely in the beauty market. Consumers should separate cosmetic products containing conditioned-media ingredients from exosome drugs that must pass formal research and registration — two entirely different standards.
Questions to ask before any exosome injection
If you are considering an exosome injection service in Thailand or Korea, ask what cells it comes from, where it is manufactured, whether contamination testing documentation exists, and what its legal status is in that country.
Last updated: 2026-08-28 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.